MedPath

The Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs

Not Applicable
Completed
Conditions
Hemophilia A
Hemophilia B
Interventions
Behavioral: Counseling
Behavioral: Control
Registration Number
NCT00212459
Lead Sponsor
New York Presbyterian Hospital
Brief Summary

The study will see if counselling adolescents with severe or moderate Hemophilia A or B results in increased compliance in the maintenance of bleeding logs.

Detailed Description

The study will see if counselling adolescents with severe or moderate Hemophilia A or B results in increased compliance in the maintenance of bleeding logs.To do this subjects will be randomized into a control group and a group who will receive consistent counselling by a pharmacist about their bleeding logs.

The aims of the study are:

* To provide a new method of bleeding and treatment documentation in the home setting (logs) to adolescent subjects with Hemophilia A or B

* To counsel these subjects about adherence to their treatment regimen prescribed by physician and the importance of keeping accurate documentation of each bleeding episode and its treatment.

* To improve maintenance of logs, to allow for 1) assessment of bleeding frequency and treatment efficacy and 2) early detection of target joint bleeding and the potential need for prophylactic factor replacement.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
14
Inclusion Criteria
  • Ages 12 through 20
  • Severe or moderate Hemophilia A or B
  • Self-infusing or transitioning to self infusion in the home setting
  • Already assigned responsibility of monitoring bleeding logs
Exclusion Criteria
  • Not meeting inclusion criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1CounselingPatients are contacted every two weeks after initial counseling to discuss completion of bleeding records.
2ControlAfter the initial counseling with regards to bleeding records, there are no more contacts made with the control patients.
Primary Outcome Measures
NameTimeMethod
Study and control groups will be compared with respect to the % of bleeds reported to the HTC and % of recommended therapy recorded in bleeding logs after a 6 month period6 months
Secondary Outcome Measures
NameTimeMethod
Study and control groups will be compared with respect to time between initiation of target joint bleeding and the identification and treatment of such by HTC personnel6 months
Clotting factor consumption and the cost of therapy in each group will be compared6 months

Trial Locations

Locations (1)

NY Presbyterian Hospital

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath